La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Carasent Gestion

Gestion contrôle des critères 0/4

Le PDG Carasent's est Daniel Ohman, nommé en Nov2022, a un mandat de 1.75 ans. détient directement 0.22% des actions de la société, d'une valeur de € 256.40K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 1.8 ans et 1.8 ans.

Informations clés

Daniel Ohman

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDG	n/a
Durée du mandat du directeur général	1.9yrs
Propriété du PDG	0.2%
Durée moyenne d'occupation des postes de direction	2yrs
Durée moyenne du mandat des membres du conseil d'administration	2yrs

Mises à jour récentes de la gestion

Recent updates

PDG

Daniel Ohman (44 yo)

1.9yrs

Titularisation

Mr. Daniel Ohman has been the Chief Executive Officer and President of GHP Specialty Care AB (publ) (formerly Global Health Partner AB (publ) since November 4, 2013 and served as its Business Area Manager...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Niclas Hugosson	Founder	no data	pas de données	3.53% NOK 4.0m
Svein Bjornstad	Chief Financial Officer	3.2yrs	pas de données	0.49% NOK 550.6k
Daniel Ohman	Chief Executive Officer	1.9yrs	pas de données	0.22% NOK 250.8k
Johan Eltes	Chief Technical Officer	2yrs	pas de données	pas de données
Jon Schultz	Legal Counsel	no data	NOK 45.00k	pas de données
Stefan Jernberg	Chief Compliance Officer	less than a year	pas de données	pas de données
Chris Damvakaris	Vice President of Sales & Business Development	no data	NOK 447.18k	pas de données
Cornelia Broqvist	Chief Marketing Officer	2.1yrs	pas de données	pas de données
Anna Larsson	People and Culture Manager	no data	pas de données	pas de données
Vilma Jonson	Head of Strategy	1.1yrs	pas de données	0.033% NOK 37.6k

2.0yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de C34 n'est pas considérée comme expérimentée (ancienneté moyenne 1.8 ans), ce qui suggère une nouvelle équipe.

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Tomas Meerits	Director	1.4yrs	pas de données	pas de données
Camilla Skoog	Independent Director	2.5yrs	pas de données	0.013% NOK 14.5k
Ulrika Sundling	Independent Director	2.5yrs	pas de données	0.028% NOK 31.1k
Petri Niemi	Independent Chairman of the Board	2yrs	pas de données	0.017% NOK 19.1k
Henric Carlsson	Independent Director	less than a year	pas de données	pas de données

2.0yrs

Durée moyenne de l'emploi

54yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de C34 ne sont pas considérés comme expérimentés (ancienneté moyenne 1.8 ans), ce qui suggère un nouveau conseil d'administration.

Carasent Gestion

Gestion contrôle des critères 0/4

Informations clés

Mises à jour récentes de la gestion

High number of new and inexperienced directors

Carasent ASA Announces Changes to Its Board

Chief Executive Officer recently bought €121k worth of stock

Founder recently bought €2.4m worth of stock

High number of new and inexperienced directors

Carasent ASA Announces Staffan Hanstorp Resigns as A Member of the Board of Directors

Recent updates

New minor risk - Share price stability

High number of new and inexperienced directors

Eg Norge A/S cancelled the acquisition of Carasent ASA (OB:CARA).

Eg Norge A/S contemplates launching a voluntary cash offer to acquire Carasent ASA (OB:CARA) for NOK 1.4 billion.

First quarter 2024 earnings released: kr0.15 loss per share (vs kr0.01 loss in 1Q 2023)

Carasent ASA Announces Changes to Its Board

Full year 2023 earnings released: kr0.60 loss per share (vs kr0.39 profit in FY 2022)

Chief Executive Officer recently bought €121k worth of stock

Full year 2023 earnings released: kr0.64 loss per share (vs kr0.39 profit in FY 2022)

Founder recently bought €2.4m worth of stock

High number of new and inexperienced directors

New major risk - Revenue and earnings growth

Carasent ASA Announces Staffan Hanstorp Resigns as A Member of the Board of Directors

Carasent ASA to Report Fiscal Year 2023 Results on Mar 22, 2024

Carasent Asa Approves Dividend

Second quarter 2023 earnings released: kr0.64 loss per share (vs kr0.03 profit in 2Q 2022)

First quarter 2023 earnings released: kr0.01 loss per share (vs kr0.32 profit in 1Q 2022)

Full year 2022 earnings released

Full year 2022 earnings released: EPS: kr0.39 (vs kr0.002 loss in FY 2021)

Carasent ASA to Report Q1, 2023 Results on May 04, 2023

High number of new and inexperienced directors

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: kr0.13 (vs kr0.28 loss in 3Q 2021)

Carasent ASA (OB:CARA) acquired HPI Health Profile Institute AB for SEK 35 million.

Carasent ASA Provides Earnings Guidance for the Third Quarter and Full Year 2022

Carasent Asa Announces That Johan Lindqvist to Step Down as Chairman of the Board

Second quarter 2022 earnings released: EPS: kr0.03 (vs kr0.34 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: kr0.32 (vs kr0.14 loss in 1Q 2021)

Dennis Höjer Informs that He Will Step Down as CEO of Carasent ASA

No independent directors

Full year 2021 earnings released: kr0.002 loss per share (vs kr0.85 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Carasent ASA (OB:CARA) completed the acquisition of Medrave Software AB.

Carasent ASA (OB:CARA) agreed to acquire Medrave Software AB for approximately SEK 130 million.

Third quarter 2021 earnings released: kr0.28 loss per share (vs kr0.21 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS kr0.34 (vs kr0.14 loss in 2Q 2020)

Chief Financial Officer Lars Forsberg has left the company

Carasent ASA announced that it has received NOK 420.155987 million in funding from Cardigan Holdco S.à r.l.

Carasent ASA (OB:CARA) acquired Metodika AB for approximately SEK 110 million.

First quarter 2021 earnings released: kr0.14 loss per share (vs kr0.01 profit in 1Q 2020)

Full year 2020 earnings released: kr0.85 loss per share (vs kr0.079 profit in FY 2019)

Aeternum Capital AS, a fund managed by Aeternum Management AS acquired 15% stake in Carasent ASA (OB:CARA).

Revenue misses expectations

New 90-day high: €3.76

Carasent ASA, Annual General Meeting, Jun 03, 2021

New 90-day high: €3.42

Carasent ASA Appoints Dennis Höjer as CEO

Carasent ASA (OB:CARA) acquired Avans Soma AS from Rieber & Søn ASA and others for approximately NOK 120 million.

New 90-day high: €2.59

Third quarter earnings released

Third quarter earnings released

Chairman recently sold €2.1m worth of stock

PDG

Titularisation

Équipe de direction

Durée moyenne de l'emploi

Membres du conseil d'administration

Durée moyenne de l'emploi

Âge moyen